Altria Q1 Adjusted EPS Beats Estimates on Strong Pricing, Backs Full-Year Outlook
MO sits 25% above its 52-week low of $54.7.
Summary
Altria reported Q1 adjusted EPS of $1.32, surpassing analyst estimates of $1.25, primarily driven by higher pricing across its smokeable and oral tobacco segments. Revenue also saw a 3.2% year-over-year increase. The company reaffirmed its 2026 full-year adjusted diluted EPS guidance of $5.56-$5.72, indicating stability despite reflecting moderated e-vapor growth and increased macroeconomic uncertainty. This positive earnings beat, following the significant e-vapor related impairments noted in its 2025 annual filing, demonstrates Altria's ability to leverage pricing power to maintain profitability amidst declining shipment volumes. Traders will view this as a positive sign of operational resilience, though continued monitoring of volume trends and e-vapor market developments will be crucial.
At the time of this announcement, MO was trading at $68.56 on NYSE in the Trade & Services sector, with a market capitalization of approximately $114B. The 52-week trading range was $54.70 to $70.51. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.